ORUM THERAPEUTICS INC.

ANDC

Biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; anti-cancer preparations; pharmaceutical compounds for treating cancer; drugs for medical purposes, namely, pharmaceutical drugs for the prevention and treatment of cancer; medicines for human purposes, namely, for the prevention and treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; pharmaceutical preparations for veterinary use, namely, veterinary pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the prevention and treatment of cancer; antibody drug conjugates for medical purposes, namely, for the prevention and treatment of cancer;

MARUMAB

antibodies for medical purposes, antibodies for medical use, monoclonal antibodies for medical purposes;monoclonal antibodies for scientific purposes, antibodies for scientific purposes;medical studies in the field of antibodies for scientific purposes; medical research in the field of antibodies;

OROMAB

monoclonal antibodies for scientific purposes;medical studies in the field of antibodies for scientific purposes; medical research in the field of antibodies;